/A

Phase 1

• Conditions: MedDRA version: 19.1Level: LLTClassification code 10036921Term: Prostate carcinomaSystem Organ Class: 100000004864; Therapeutic area: Diseases [C] - Cancer [C04]

• Registration Number: EUCTR2016-001361-81-FR
• Lead Sponsor: INSTITUT DE CANCEROLOGIE DE L'OUEST

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2017-02-17
• Last Update Posted: 13 March 2017

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: Male
• Target Recruitment: Not specified

Inclusion Criteria

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 40
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 90

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main Objective: ;Secondary Objective: ;Primary end point(s):